Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2013View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerMay 9, 2013Download DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 6, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 1, 2013View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionApr 29, 2013View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventApr 25, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 23, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-153

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information